Infertility Clinical Trial
Official title:
Female Subfertility: a First Sign of Metabolic and Cardiovascular Anomalies?
Introduction:
Overall, 10 - 15% of couples seek specialist help once in their lives when a spontaneous
pregnancy does not occur. These couples are defined subfertile when there is at least one
year of unprotected intercourse without conceiving. Subfertility can have different causes
which can be diagnosed with a basic fertility work-up. Unfortunately, the subfertility in
25% of the couples still remains unexplained.
Hypothesis:
The investigators hypothesize that cardio-metabolic and hemodynamic abnormalities reducing
cardiovascular reserves relate to circulatory redistribution at the expense of uterine
perfusion and with it women's fertility. This could especially be important in the subgroups
with an unexplained subfertility and a decreased ovarian reserve. Interventions to improve
these abnormalities could lead to better results in fertility treatment, better obstetric
outcome and reduced lifelong health risks.
Objective:
The investigators want to examine specific cardio-metabolic and cardiovascular parameters in
women of subfertile couples. The investigators want to evaluate the prevalence of metabolic
syndrome in all women who are assessed for subfertility compared to healthy parous women.
Furthermore in the women with an unexplained subfertility or with (signs of) a decreased
ovarian reserve the cardiovascular profile will be studied consisting of the uterine artery
pulsatility index (PI) as measure of uterine perfusion, the plasma volume as measure of
venous reserve capacity, the intima media thickness of the carotid arteries as proxy of
chronic strain and the endothelial function, measured by flow mediated dilatation (FMD) of
the brachial artery.
Study design:
Cross-sectional
Study population:
The study group consists of subfertile women between 18 and 41 years who visit the fertility
clinic in the Maastricht University Medical Centre with a primary or secondary subfertility.
Women with an unexplained subfertility or with (signs of) a decreased ovarian reserve are
evaluated for their cardiovascular profile. The control group consists of women with a
history of an uneventful spontaneous pregnancy.
Main study parameters:
1. Prevalence of metabolic syndrome in subfertile women
2. The cardiovascular profile, in women with an unexplained subfertility or with (signs
of) a decreased ovarian reserve, consisting of:
- The uterine artery pulsatility index
- The plasma volume
- The intima media thickness (IMT)
- The endothelial function of the vascular system (FMD)
Introduction:
Overall, 10 - 15% of couples seek specialist help once in their lives when a spontaneous
pregnancy does not occur. These couples are defined subfertile when there is at least one
year of unprotected intercourse without conceiving. Subfertility can have different causes.
A basic fertility work-up focuses on the reproductive system of the couple. After this basic
fertility work-up the subfertility remains unexplained in 16-24% of the couples. The
investigators hypothesize that cardio-metabolic and hemodynamic abnormalities reducing
cardiovascular reserves relate to circulatory redistribution at the expense of uterine
perfusion and with it women's fertility. This could especially be important in the subgroups
with an unexplained subfertility and a decreased ovarian reserve. For all possible assessed
abnormalities, proven effective treatments are available such as primarily life style
corrective actions. Furthermore these interventions could lead to better results in
fertility treatment, better obstetric outcome and reduced lifelong health risks.
Objective:
The overall objective of this study is to examine specific cardio-metabolic and
cardiovascular parameters in women of subfertile couples. This study protocol is divided
into 3 studies to evaluate several cardio-metabolic/cardiovascular parameters in different
subgroups of female subfertility compared to fertile women.
- Study 1 "The metabolic syndrome and female subfertility": The prevalence of metabolic
syndrome in all women who are assessed for subfertility compared to fertile women.
- Study 2 "The cardiovascular profile in female subfertility": The cardiovascular profile
of women with female subfertility classified as unexplained subfertility or "expected"
decreased ovarian reserve compared to fertile women. For this study 4 measurements will
be performed: the uterine artery pulsatility index (PI) as measure of uterine
perfusion, the plasma volume as measure of venous reserve capacity, the intima media
thickness of the carotid arteries as proxy of chronic strain and the endothelial
function, measured by flow mediated dilatation (FMD) of the brachial artery.
- Study 3 "The cardiovascular profile of women with a poor ovarian response": The
cardiovascular profile of women who had an In Vitro Fertilisation (IVF) population with
a "proven" decreased ovarian reserve
With these different studies, the investigators hope to identify possible
cardio-metabolic/cardiovascular causes for female subfertility. This can lead to new
treatment options for female subfertility, enhancing reproductive and obstetric outcome, and
a risk assessment for later in life.
Study design:
We want to perform cross-sectional studies.
Study population:
Study 1:
- Study group: subfertile women between 18 and 41 years who visit the fertility clinic in
the Maastricht University Medical Centre with a primary or secondary subfertility,
independent of the cause of their subfertility
- Control group: women with a history of an uneventful spontaneous pregnancy
Study 2: Women who finished the basic fertility work up and are diagnosed with:
- an unexplained subfertility: study group 1
- an "expected" decreased ovarian reserve: study group 2 Control group: women with a
history of an uneventful spontaneous pregnancy
Study 3: Women who received an IVF treatment in the period of 2010 - 2012 and:
- study group: had a "proven" decreased ovarian response, defined as retrieving 3 oocytes
or less at an ovum pick-up, despite maximal ovarian stimulation
- control group: received and IVF/Intracytoplasmic Sperm Injection (ICSI) treatment
because of a severe male subfertility
Main study parameters:
Study 1: Prevalence of metabolic syndrome in subfertile women compared to fertile controls.
Study 2: The cardiovascular profile, in women with an unexplained subfertility or an
"expected" decreased ovarian reserve, consisting of:
1. The uterine artery pulsatility index as measure for uterine perfusion
2. The plasma volume as measure for venous reserve capacity
3. The intima media thickness (IMT) of the carotid arteries as proxy for chronic strain
4. The endothelial function of the vascular system (FMD)
Study 3: The cardiovascular profile, in women with a poor ovarian response, consisting of:
1. The uterine artery pulsatility index as measure for uterine perfusion
2. The plasma volume as measure for venous reserve capacity
3. The intima media thickness (IMT) of the carotid arteries as proxy for chronic strain
4. The endothelial function of the vascular system (FMD)
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A |